Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters

A. Ben Yehuda, Izidore Lossos, R. Or, E. Ben Chetrit, R. H. Goldstein, M. W. Conner, R. Breuer

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We have evaluated the effect of colchicine, a potential antifibrotic drug, on bleomycin-induced pulmonary inflammation in hamsters. Pulmonary injury was induced by a single intratracheal (IT) instillation of bleomycin (bleo). Four groups of male Syrian hamsters each received one of four treatments: (1) IT bleo and twice daily intraperitoneal (IP) injections of colchicine (col) starting one day before IT instillation of bleo (bleo-col); (2) IT bleo and IP injections of saline (bleo-sal); (3) IT saline and LP colchicine (sal-col); and (4) IT saline and IP saline (sal-sal). Animals were sacrificed 28 days after IT treatment. Lung injury was evaluated histologically, biochemically and by analysis of bronchoalveolar lavage (BAL) fluid. Treatment of hamsters with colchicine did not ameliorate the bleo-induced lung injury, as determined by a semiquantitative morphological index that assesses the severity and extent of the lung injury on a scale of 0-3. Lung hydroxyproline measurements and BAL fluid cell count were also similar in bleo-col compared to bleo-sal hamsters. Colchicine did not prevent the bleo-induced restriction expressed by volume displacement. These results indicate that colchicine does not ameliorate the bleo-induced lung inflammation and fibrosis and call for further controlled investigations to justify the use of this drug in pulmonary disorders.

Original languageEnglish
Pages (from-to)61-65
Number of pages5
JournalPulmonary Pharmacology and Therapeutics
Volume10
Issue number1
DOIs
StatePublished - Feb 1 1997
Externally publishedYes

Fingerprint

Bleomycin
Colchicine
Lung Injury
Cricetinae
Bronchoalveolar Lavage Fluid
Intraperitoneal Injections
Pneumonia
Lung
Fluids
Hydroxyproline
Mesocricetus
Pharmaceutical Preparations
Animals
Fibrosis
Therapeutics
Cell Count

Keywords

  • Bleomycin
  • Colchicine
  • Hamster
  • Interstitial lung disease

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology

Cite this

Yehuda, A. B., Lossos, I., Or, R., Chetrit, E. B., Goldstein, R. H., Conner, M. W., & Breuer, R. (1997). Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters. Pulmonary Pharmacology and Therapeutics, 10(1), 61-65. https://doi.org/10.1006/pupt.1997.0076

Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters. / Yehuda, A. Ben; Lossos, Izidore; Or, R.; Chetrit, E. Ben; Goldstein, R. H.; Conner, M. W.; Breuer, R.

In: Pulmonary Pharmacology and Therapeutics, Vol. 10, No. 1, 01.02.1997, p. 61-65.

Research output: Contribution to journalArticle

Yehuda, A. Ben ; Lossos, Izidore ; Or, R. ; Chetrit, E. Ben ; Goldstein, R. H. ; Conner, M. W. ; Breuer, R. / Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters. In: Pulmonary Pharmacology and Therapeutics. 1997 ; Vol. 10, No. 1. pp. 61-65.
@article{93f5d47dd19e4a81be45d7e4a6ace353,
title = "Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters",
abstract = "We have evaluated the effect of colchicine, a potential antifibrotic drug, on bleomycin-induced pulmonary inflammation in hamsters. Pulmonary injury was induced by a single intratracheal (IT) instillation of bleomycin (bleo). Four groups of male Syrian hamsters each received one of four treatments: (1) IT bleo and twice daily intraperitoneal (IP) injections of colchicine (col) starting one day before IT instillation of bleo (bleo-col); (2) IT bleo and IP injections of saline (bleo-sal); (3) IT saline and LP colchicine (sal-col); and (4) IT saline and IP saline (sal-sal). Animals were sacrificed 28 days after IT treatment. Lung injury was evaluated histologically, biochemically and by analysis of bronchoalveolar lavage (BAL) fluid. Treatment of hamsters with colchicine did not ameliorate the bleo-induced lung injury, as determined by a semiquantitative morphological index that assesses the severity and extent of the lung injury on a scale of 0-3. Lung hydroxyproline measurements and BAL fluid cell count were also similar in bleo-col compared to bleo-sal hamsters. Colchicine did not prevent the bleo-induced restriction expressed by volume displacement. These results indicate that colchicine does not ameliorate the bleo-induced lung inflammation and fibrosis and call for further controlled investigations to justify the use of this drug in pulmonary disorders.",
keywords = "Bleomycin, Colchicine, Hamster, Interstitial lung disease",
author = "Yehuda, {A. Ben} and Izidore Lossos and R. Or and Chetrit, {E. Ben} and Goldstein, {R. H.} and Conner, {M. W.} and R. Breuer",
year = "1997",
month = "2",
day = "1",
doi = "10.1006/pupt.1997.0076",
language = "English",
volume = "10",
pages = "61--65",
journal = "Pulmonary Pharmacology and Therapeutics",
issn = "1094-5539",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Colchicine does not ameliorate bleomycin-induced pulmonary injury in hamsters

AU - Yehuda, A. Ben

AU - Lossos, Izidore

AU - Or, R.

AU - Chetrit, E. Ben

AU - Goldstein, R. H.

AU - Conner, M. W.

AU - Breuer, R.

PY - 1997/2/1

Y1 - 1997/2/1

N2 - We have evaluated the effect of colchicine, a potential antifibrotic drug, on bleomycin-induced pulmonary inflammation in hamsters. Pulmonary injury was induced by a single intratracheal (IT) instillation of bleomycin (bleo). Four groups of male Syrian hamsters each received one of four treatments: (1) IT bleo and twice daily intraperitoneal (IP) injections of colchicine (col) starting one day before IT instillation of bleo (bleo-col); (2) IT bleo and IP injections of saline (bleo-sal); (3) IT saline and LP colchicine (sal-col); and (4) IT saline and IP saline (sal-sal). Animals were sacrificed 28 days after IT treatment. Lung injury was evaluated histologically, biochemically and by analysis of bronchoalveolar lavage (BAL) fluid. Treatment of hamsters with colchicine did not ameliorate the bleo-induced lung injury, as determined by a semiquantitative morphological index that assesses the severity and extent of the lung injury on a scale of 0-3. Lung hydroxyproline measurements and BAL fluid cell count were also similar in bleo-col compared to bleo-sal hamsters. Colchicine did not prevent the bleo-induced restriction expressed by volume displacement. These results indicate that colchicine does not ameliorate the bleo-induced lung inflammation and fibrosis and call for further controlled investigations to justify the use of this drug in pulmonary disorders.

AB - We have evaluated the effect of colchicine, a potential antifibrotic drug, on bleomycin-induced pulmonary inflammation in hamsters. Pulmonary injury was induced by a single intratracheal (IT) instillation of bleomycin (bleo). Four groups of male Syrian hamsters each received one of four treatments: (1) IT bleo and twice daily intraperitoneal (IP) injections of colchicine (col) starting one day before IT instillation of bleo (bleo-col); (2) IT bleo and IP injections of saline (bleo-sal); (3) IT saline and LP colchicine (sal-col); and (4) IT saline and IP saline (sal-sal). Animals were sacrificed 28 days after IT treatment. Lung injury was evaluated histologically, biochemically and by analysis of bronchoalveolar lavage (BAL) fluid. Treatment of hamsters with colchicine did not ameliorate the bleo-induced lung injury, as determined by a semiquantitative morphological index that assesses the severity and extent of the lung injury on a scale of 0-3. Lung hydroxyproline measurements and BAL fluid cell count were also similar in bleo-col compared to bleo-sal hamsters. Colchicine did not prevent the bleo-induced restriction expressed by volume displacement. These results indicate that colchicine does not ameliorate the bleo-induced lung inflammation and fibrosis and call for further controlled investigations to justify the use of this drug in pulmonary disorders.

KW - Bleomycin

KW - Colchicine

KW - Hamster

KW - Interstitial lung disease

UR - http://www.scopus.com/inward/record.url?scp=0031079089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031079089&partnerID=8YFLogxK

U2 - 10.1006/pupt.1997.0076

DO - 10.1006/pupt.1997.0076

M3 - Article

C2 - 9344834

AN - SCOPUS:0031079089

VL - 10

SP - 61

EP - 65

JO - Pulmonary Pharmacology and Therapeutics

JF - Pulmonary Pharmacology and Therapeutics

SN - 1094-5539

IS - 1

ER -